Han‐Yue Qiu

1.2k total citations
52 papers, 967 citations indexed

About

Han‐Yue Qiu is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Han‐Yue Qiu has authored 52 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 22 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Han‐Yue Qiu's work include Bioactive Compounds and Antitumor Agents (9 papers), Synthesis and biological activity (9 papers) and Synthesis and Biological Evaluation (9 papers). Han‐Yue Qiu is often cited by papers focused on Bioactive Compounds and Antitumor Agents (9 papers), Synthesis and biological activity (9 papers) and Synthesis and Biological Evaluation (9 papers). Han‐Yue Qiu collaborates with scholars based in China, Czechia and Pakistan. Han‐Yue Qiu's co-authors include Pengfei Wang, Hai‐Liang Zhu, Yonghua Yang, Xiaoming Wang, Jinliang Qi, Cheng‐Yi Tang, Zhong‐Chang Wang, Min Zhang, Hongyan Lin and Guihua Lu and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Han‐Yue Qiu

51 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han‐Yue Qiu China 19 625 379 200 125 102 52 967
Mostafa A. Elhendawy Egypt 13 626 1.0× 444 1.2× 162 0.8× 123 1.0× 83 0.8× 20 950
C. S. Ramaa India 18 643 1.0× 483 1.3× 71 0.4× 109 0.9× 85 0.8× 51 1.1k
Belgin Sever Türkiye 23 951 1.5× 631 1.7× 99 0.5× 187 1.5× 249 2.4× 79 1.6k
Asmaa E. Kassab Egypt 16 691 1.1× 391 1.0× 78 0.4× 100 0.8× 180 1.8× 56 1.0k
Halil I. Ciftci Japan 19 500 0.8× 397 1.0× 180 0.9× 109 0.9× 42 0.4× 51 922
Hong Yao China 24 524 0.8× 856 2.3× 85 0.4× 167 1.3× 209 2.0× 57 1.4k
Abdullah Al‐Dhfyan Saudi Arabia 21 575 0.9× 455 1.2× 83 0.4× 223 1.8× 64 0.6× 47 1.1k
Süreyya Ölgen Türkiye 21 532 0.9× 341 0.9× 110 0.6× 72 0.6× 90 0.9× 67 921
Abdel‐Ghany A. El‐Helby Egypt 19 869 1.4× 576 1.5× 164 0.8× 180 1.4× 34 0.3× 20 1.2k
Rezk R. Ayyad Egypt 25 1.1k 1.8× 691 1.8× 119 0.6× 174 1.4× 117 1.1× 52 1.5k

Countries citing papers authored by Han‐Yue Qiu

Since Specialization
Citations

This map shows the geographic impact of Han‐Yue Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Yue Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Yue Qiu more than expected).

Fields of papers citing papers by Han‐Yue Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Yue Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Yue Qiu. The network helps show where Han‐Yue Qiu may publish in the future.

Co-authorship network of co-authors of Han‐Yue Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Yue Qiu. A scholar is included among the top collaborators of Han‐Yue Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Yue Qiu. Han‐Yue Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yankun, Yulian Zhang, Tao Zhou, et al.. (2024). Catalytic asymmetric intramolecular propargylation of cyclopropanols to access the cuparane core. Chemical Science. 15(28). 10963–10968.
2.
Jiang, Dan, Hongbing Xiong, Yulian Zhang, et al.. (2023). A Homo‐Mannich Reaction Strategy Enables Collective Access to Ibophyllidine, Aspidosperma, Kopsia, and Melodinus Alkaloids. Angewandte Chemie. 135(37). 1 indexed citations
3.
Zhou, Wenqiang, Song Xi, Haohua Chen, et al.. (2023). A bridged backbone strategy enables collective synthesis of strychnan alkaloids. Nature Chemistry. 15(8). 1074–1082. 18 indexed citations
4.
Qiu, Han‐Yue, Pengfei Wang, & Min Zhang. (2021). A patent review of mTOR inhibitors for cancer therapy (2011–2020). Expert Opinion on Therapeutic Patents. 31(11). 965–975. 8 indexed citations
5.
Wang, Pengfei, Han‐Yue Qiu, & Hai‐Liang Zhu. (2019). A patent review of BRAF inhibitors: 2013-2018. Expert Opinion on Therapeutic Patents. 29(8). 595–603. 9 indexed citations
6.
Shen, Fa-Qian, Lu Shi, Zefeng Wang, et al.. (2019). Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry. 27(17). 3813–3824. 16 indexed citations
7.
Wang, Pengfei, Zefeng Wang, Zefeng Wang, et al.. (2018). Identification and Biological Evaluation of Novel Type II B‐RafV600E Inhibitors. ChemMedChem. 13(23). 2558–2566. 7 indexed citations
8.
Wang, Pengfei, Han‐Yue Qiu, Zefeng Wang, et al.. (2017). Identification of novel B-RafV600E inhibitors employing FBDD strategy. Biochemical Pharmacology. 132. 63–76. 17 indexed citations
9.
Qiu, Han‐Yue, Fang Wang, Xue Wang, et al.. (2017). Design, Synthesis, and Biological Evaluation of Chalcone‐Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization. ChemMedChem. 12(5). 399–406. 26 indexed citations
11.
Wang, Zizhen, Wenxue Sun, Xue Wang, et al.. (2017). Design, synthesis, biological evaluation, and 3D‐QSAR analysis of podophyllotoxin–dioxazole combination as tubulin targeting anticancer agents. Chemical Biology & Drug Design. 90(2). 236–243. 18 indexed citations
12.
Qiu, Han‐Yue, Jiangyan Fu, Minkai Yang, et al.. (2017). Identification of new shikonin derivatives as STAT3 inhibitors. Biochemical Pharmacology. 146. 74–86. 37 indexed citations
13.
Zhang, Qi‐Lin, et al.. (2017). Exploring gene expression changes in the amphioxus gill after poly(I:C) challenge using digital expression profiling. Fish & Shellfish Immunology. 70. 57–65. 15 indexed citations
14.
Qiu, Han‐Yue, Pengfei Wang, Zizhen Wang, et al.. (2016). Shikonin derivatives as inhibitors of tyrosyl-tRNA synthetase: design, synthesis and biological evaluation. RSC Advances. 6(86). 83003–83010. 4 indexed citations
15.
Han, Hongwei, Han‐Yue Qiu, Wenxue Sun, et al.. (2016). Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs. Bioorganic & Medicinal Chemistry Letters. 26(14). 3237–3242. 24 indexed citations
16.
Lin, Hongyan, Lifei Bai, Fang Wang, et al.. (2015). Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization. Biochemical Pharmacology. 96(2). 93–106. 26 indexed citations
17.
Qiu, Han‐Yue, Pengfei Wang, Zhen Li, et al.. (2015). Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition. Pharmacological Research. 104. 86–96. 43 indexed citations
18.
Lin, Hongyan, Hongwei Han, Han‐Yue Qiu, et al.. (2015). Synthesis of novel aryl dithian valeryl podophyllotoxin ester derivatives as potential antitubulin agents. RSC Advances. 5(59). 47511–47521. 9 indexed citations
19.
Qiu, Han‐Yue, Zhong‐Chang Wang, Pengfei Wang, et al.. (2014). Design, synthesis, evaluation and 3D-QSAR analysis of benzosulfonamide benzenesulfonates as potent and selective inhibitors of MMP-2. RSC Advances. 4(74). 39214–39214. 12 indexed citations
20.
Yuan, Jiwen, Han‐Yue Qiu, Pengfei Wang, et al.. (2014). Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. Bioorganic & Medicinal Chemistry Letters. 24(10). 2324–2328. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026